...Global Talent Management at Novartis Novartis is one of the largest pharmaceutical companies in the world that spans across 140 countries. Daniel Vasella, CEO, has transformed Novartis into a 100% healthcare company by ridding the company of its specialty chemicals business. By doing so, Novartis became the second largest producer of generic drugs. Vasella reconstructed the company’s approach towards global talent management since the previous approach lacked regular performance review, global objectives, and incentive based pays as a deterrent of motivation. Vasella implemented a universal performance management system and new culture, which is based on candor, performance, and accountability. The key issue involves contradictions with Novartis’s past culture and Vasella’s new culture. The new list of values and behaviors lacks cultural sensitivity and does not reflect the culture that has developed at Novartis. Vasella must implement a plan that includes values and behaviors that are adaptable and based on local cultures to minimize ethnocentrism. Through contingency management, this goal may be achieved because this concept uses management tools and techniques in a situational appropriate behavior, which will avoid the one-best-way mentality. Vasella’s new list of values and behaviors may include: be productive, be innovative, be proactive, be accountable, and be respectful. Top performing companies are more likely to have performance-based rewards, so Vasella should...
Words: 303 - Pages: 2
...9-708-486 REV: NOVEMBER 14, 2008 JORDAN SIEGEL Global Talent Management at Novartis Introduction Novartis CEO Daniel Vasella, M.D., was sitting in his first-floor office in 2007 in Basel, Switzerland, reflecting to an outside researcher about the path that had led to his becoming CEO, and the origins of his (and his company’s) philosophy around global talent management. In presentations Vasella gave to Novartis employees around the world, he continually emphasized that talent identification, the use of systematic talent development, and strong pay-for-performance were central tasks and responsibilities for the company and every manager. With regard to his and the company’s philosophy on accountability and incentive pay-for-performance, Vasella noted: “The best time to form views about management is before you come to the top. You see how the real world works and how bureaucracy works, and what people believe and never dare to challenge.” Vasella had spent five years in the U.S. as a manager for one of the predecessor companies to Novartis, and during that time he had learned about and embraced new models of incentive pay-for-performance that were being pioneered at General Electric: I was listening to what Jack Welch had to say in 1988/89 and I saw that they had a far better human resource and incentive system than we did in my company. I transferred back to home base in Switzerland in 1992, just after we had introduced variable incentive compensation in my U.S. operation...
Words: 6761 - Pages: 28
...markets and international competition are increasing the amount of diversity organizations must manage, both internally and externally. Diversity specialists (Soutar, 2004; Yang, 2005) have suggested in that in order for businesses and organizations interested in prospering and surviving in the twenty-first century embracing the competitive advantage afforded by a diverse workplace is needed This report looks at the impact of managing diversity in the workplace and the performance and financial benefits which can be gained from successful management. Novartis Pharmaceuticals is one such company which has placed emphasis on embracing and managing diversity and using this to the company’s advantage. The Company Novartis is a global healthcare company founded in 1996 headquarted in Basel Switzerland with a presence in 140 countries providing medical solutions to the evolving needs of patients worldwide (Novartis.com, 2015). Novartis International AG employs approximately 135,696 employees and is also, ranked number one in sales earning US 58.4 billion in 2014. (Wikipedia.com, 2015). The company produces...
Words: 2250 - Pages: 9
...a 75% margin on the transfer price. Program OTC launched in February 2001, and had over $10 million in sales by the end of the year. As a result of the deal, in 2001 AH Japan had the best profit margin of any AH business. 5. Play critical roles as Catalyst; CFOs can stimulate and drive the timely execution of change in the finance function or the enterprise. Using the power of their purse strings, they can selectively drive business improvement initiatives such as improved enterprise cost reduction, procurement, pricing execution, and other process improvements and innovations that add value to the company. Remi Escurel is Gaining business alignment to successfully identify, evaluate and execute strategies by partnering with senior management, Also Being a business partner with other executives such as the CIO, CMO, General Counsel or CLO, Head of HR and business unit leaders. Remi worked very closely with Regional Head Dennis Marnon. They have very frequent interaction. And have an excellent relationship. Beyond the traditional finance role, Remi acts as a sounding board for regional...
Words: 1523 - Pages: 7
...Cultural Diversity in Life Sciences Janet Chauhan Chamberlain College of Nursing SOCS350: Cultural Diversity in Professions Spring May 2016 Cultural Diversity in Life Sciences Cultural diversity in professions is a critical success factor in all aspects of business, but none as much as in Life Sciences. The webpage and company chosen to research cultural diversity in life sciences is Bayer.com. According to Bayer’s website, Bayer is a global company operating in almost all markets in the world for a little over 150 years. For a company with such a long history of over 150 years and operating in 120 countries with a little over 100 thousand employees, the question is how culturally diverse is Bayer? Introduction Bayer was chosen to research cultural diversity for the inherent nature of the diversity in the company itself. Being that Bayer is so diverse, how does the bayer.com webpage portray cultural diversity. Germany is the largest country in the European Union, and Bayer is in the Top 5 companies from a market valuation perspective on the German stock exchange. As all multinational companies, and United States (US) being the largest market in the world, Bayer also has a very large presence in the US. Finally, the business model is very interesting where Bayer has three main pillars of business; 1) Pharmaceuticals (prescription medication), 2) Consumer Health (over the counter general medicines) and finally 3) Crop Science (crop protection and growth). Since Bayer...
Words: 1314 - Pages: 6
...Business Strategy of Sandoz Bangladesh Term Paper on Business Strategy of Sandoz Bangladesh Submitted to Professor A K M Saiful Majid Course Instructor, Business Strategy (W650) Submitted by M Nakibur Rahman, Batch: 43D, Roll# 55 Wazedur Rahman, Batch: 46D, Roll# 143 Institute of Business Administration University of Dhaka 13 June 2013 Dr. A K M Saiful Majid Professor Institute of Business Administration University of Dhaka Dear Sir: We are pleased to submit our term paper on “Business Strategy of Sandoz Bangladesh” as per your kind guidance and instructions to fulfill the course requirements. Working for the paper had been of great learning experience for us. This project gave us the opportunity to analyze a real life sector that we could relate with the theoretical issues studied in the Business Strategy course. We are open to your queries and feedback regarding this report. Yours truly, Mohammad Nakibur Rahman Roll: 55, Batch: 43D Wazedur Rahman Roll: 143, Batch: 46D i Table of Contents Executive Summary ....................................................................... iii 1. Introduction ............................................................................. 1 1.1 1.2 Objective ................................................................................................................................. 1 Scope .............................................................................................................
Words: 3508 - Pages: 15
...RESOURCES MANAGING TECHNOLOGY FINANCE & ACCOUNTING ORGANIZATION & CULTURE MARKETING STRATEGY & COMPETITION HUMAN RESOURCES MANAGING TECHNOLOGY MARKETING STRATEGY & Honing Your HUMAN RESOURCES ORGANIZATION & CULTURE FINANCE & ACCOUNTING HUMAN RESOURCES COMPETITIONCompetitive Edge Finance Function in a Global Corporation The H 108 Harvard Business Review | by Mihir A. Desai HISTORICALLY, the finance functions in large U.S. and European firms have focused on cost control, operating budgets, and internal auditing. But as corporations go global, a world of finance opens up within them, presenting new opportunities and challenges for CFOs. Rather than simply make aggregate capital-structure and dividend decisions, for example, they also have to wrestle with the capital structure and profit repatriation policies of their companies’ subsidiaries. Capital budgeting decisions and valuation must reflect not only divisional differences but also the complications introduced by currency, tax, and country risks. Incentive systems need to measure and reward managers operating in various economic and financial settings. The existence of what amounts to internal markets for capital gives global corporations a powerful mechanism for arbitrage across national financial markets. But in managing their July–August 2008 | hbr.org John Hersey Honing Your Competitive Edge FINANCE & ACCOUNTING internal markets to create a competitive advantage, finance executives must delicately...
Words: 2206 - Pages: 9
...Pharmaceutical Industry Edward C. Twyford August 25, 2013 MBA 525 Professional Development Abstract With the advent of healthcare reform, increased government regulation and market saturation the pharmaceutical industry has been faced with a multitude of challenges. Scrutiny as to over cost of pharmaceutical sales organization has gained popularity with senior pharmaceutical executives as well as Wall Street Analysts. Both parties attempted to put a price tag on the sales organization in comparison to direct sales. Faced with no comprehensive data based tool for this evaluation, most evaluations where left to speculation and subjective conclusions. In 2008 Andris A. Zoltners, Ph.D. and Sally E. Lorimer, M.M. both from the Kellogg School of Management at Carnegie Mellon University collaborated with Prabhakant Sinha, Ph.D. from the University of Massachusetts to publish the foundation of Sales Force Effectiveness Framework. This framework applied to pharmaceutical sales organizations worldwide defined the study of effectiveness in these organizations. We will define Sales Force Effectiveness Framework and look at the methodology used to arrive at this template. We will then explain the drivers, the key components, of SFEF and look at examples of SFEF incorporated in sales force evaluation. Through these examples one the ability for companies to use cross functional teams to better and more efficiently solve problems is evident. Another aspect of SFEF is its ability to define areas of...
Words: 2534 - Pages: 11
...Pradeep Kashyap Founder & CEO, MART He is known as the Father of Rural India (title bestowed on him by Late Prof C K Prahalad in his book Fortune at the Bottom of the Pyramid). He is a Global thought leader. He is a sought after speaker and has given over 500 talks across the globe at CEO forums, Global Investor meets, conferences and industry events. Public Life and Social Entrepreneurship After working for 17 years with MNCs he voluntarily opted out of the corporate world to serve the poor. In 1993 he started MART as a ‘Business Mind Social Heart’ organization based on ethical and spiritual principles. MART has given marketing advice to many social enterprises in India, Nepal and Bangladesh. He has been Marketing Advisor to Ministry of Rural Development, GoI; Chairman, Khadi Commission national marketing committee and has served on Prime Minister Office and Chief Minister Committees on rural development. He is a World Bank and United Nations consultant; and member of national advisory committees of RBI, NABARD and SIDBI. Creation of jobs/self-employment His efforts have created sustainable livelihoods for nearly 200,000 rural poor • As marketing advisor to the government in 1989 he started Gramshree melas for sale of rural products in urban areas. 300 melas have been held in 75 cities creating sustainable livelihoods for 100,000 rural producers. • He co-created the world famous Project Shakti (case study at Harvard) with Hindustan Unilever to appoint 46...
Words: 621 - Pages: 3
...[pic][pic][pic] | | | | | | The Too-Fast Track China’s rapid economic expansion has revealed a paucity of leadership talent, prompting companies to elevate young managers who oftentimes lack the necessary tools but, regardless, are highly sought after by competitors and can change jobs almost at will. By Ed Frauenheim [pic] s vice president of Hyatt International Hotels and Resorts for China and Taiwan, Edward Tai has promoted countless employees during his 34-year career with the upscale hotel chain. In fact, the affable 62-year-old China native says Hyatt often creates elaborate four-year plans to groom up-and-coming execs to head a department in China. But some of those rising stars—and many of Hyatt’s competitors—can’t endure a lengthy development pro¬cess. In leadership-starved China, raiding the competition in search of people who display a shred of managerial potential is all too common. And it’s penalizing executives like Tai, who wants to do things the right way. "By the second year, we do not think he is quite ready," Tai says. "But the other hotel chains, or other places, thinking he is from a Hyatt...
Words: 2816 - Pages: 12
...effective international mobility program (take care employees needs like personal, financial, social etc.) Economic: • Increase in energy and raw material prices in Europe and US(chemical industry)Relocate facilities to Asia and middle east because of high demand and low labour cost • High competition from companies like Novartis, PolyOne Need to expand into new areas • Movement of HR helps in easy expansion Need of an effective international mobility program • As Solvay’s policy of growing talent within the company Need of effective international mobility Legal: • EC’s regulatory package (REACH)in chemical industry High compliance costMade European market less lucrativeExpansion into global markets • Requirement of expatriates Effective expat process Social/Cultural: • Cultural difference in different countries • Increasing consumer buying power • Mobility program to train and allocate employees SWOT Analysis of International mobility program: Strengths: • Helps in growing talent within company • Selection based on PDA • Talent roundtables - helps in talent identification process • Focus on in-career management • Site management which helps in succession planning and career development • Potential pool- ensures proper staffing at all the levels at all times • High retention rate (90%) Weakness: • Personal influence and political aspects were important decision drivers. • Lack of transparency • Uncertainty in the program. • Package calculation not much...
Words: 1003 - Pages: 5
...AT E C I T I Z E N S H I P 8 5 | C O R P O R AT E G O V E R N A N C E 111 | C O M P E N S AT I O N R E P O R T 1 31 | F I N A N C I A L R E P O R T 1 2 N OVART I S G R OU P AN N UA L R E PO R T 2 010 CONTENTS GROUP REVIEW Financial Highlights News in 2010 Letter from Daniel Vasella Interview with Joseph Jimenez 4 5 7 15 19 23 35 39 45 51 57 61 67 73 78 83 85 90 101 111 112 HEALTHCARE PORTFOLIO Contents Pharmaceuticals Novartis Institutes for BioMedical Research Vaccines and Diagnostics Sandoz Consumer Health CORPORATE CITIZENSHIP Contents Commitment to Patients Commitment to People and Communities Commitment to the Environment Commitment to Ethical Business Conduct Independent Assurance Report CORPORATE GOVERNANCE Contents Our Board of Directors Our Management COMPENSATION REPORT Contents Compensation Report NOVARTIS GROUP FINANCIAL REPORT Contents Operating and Financial Review Equity Strategy Novartis Group Consolidated Financial Statements Financial Statements of Novartis AG Annual Report Photography Key Dates 2011, Contact Information and Forward-Looking Statements 131 134 177 180 252 268 270 4 | GROUP REVIEW 19 | H E A LT H C A R E P O R T F O L I O 57 | C O R P O R AT E C I T I Z E N S H I P 8 5 | C O R P O R AT E G O V E R N A N C E 111 | C O M P E N S AT I O N R E P O R T 1 31 | F I N A N C I A L R E P O R T 3...
Words: 8604 - Pages: 35
...governments around the world to engage in Neo-Keynesian policies in order to consolidate the stumbling global financial system. More recently the ‘Eurozone’ crisis has called into question one of the most ambitious international cooperations and has seen populations asking for more protectionism. In the Middle East, dictatorial regimes have been ousted by the revolutionary ‘Arab Spring’ and the newly formed governments are trying to find a way between global exchange and Islamic tradition. During these difficult times, emerging countries from Asia, Latin America and Africa have increasingly asserted their newly found economic and financial power and demanded a bigger participation in world governance. The tsunami that struck Fukushima in Japan in March 2011 creating a nuclear accident has convinced many nations to reconsider their energy policy. Despite all of this, globalization, even though criticized, is still active. Firms are moving to the new emerging economies in order to capture the consumption appetite of the growing middle classes. It is still relevant and important to put together all aspects of global strategic management. This third edition is still about global firms and global management. Its objective remains to help undergraduate and graduate students, as well as company executives, to understand the main issues that companies and their managers confront when they ‘go global’ or ‘manage globally’, and to cope with these issues. Data have been updated and several new cases...
Words: 2794 - Pages: 12
...BANGALORE Final Report for Contemporary Concerns Study Project Repositioning Strategy for Indian Pharmaceutical Companies in Global Context Submitted to PROFESSOR MURALI PATIBANDLA (FACULTY,CORPORATE STRATEGY AND POLICY) Submitted By Ravela Madhurika- 1211132 Tanveer Mohd Ansari-1211151 Contents Introduction .................................................................................................................................................. 3 Global Pharma Industry ............................................................................................................................ 3 Major players of the world pharmaceutical industry ................................................................................... 5 Major Players ............................................................................................................................................ 6 Pfizer Inc................................................................................................................................................ 6 GlaxoSmithKline .................................................................................................................................... 6 Sanofi-Aventis ....................................................................................................................................... 6 Novartis ...........................................................................................................................
Words: 7934 - Pages: 32
...The Pharmaceutical industry in the Global Economy Summer 2005 Larry Davidson* and Gennadiy Greblov Indiana University Kelley School of Business Bloomington, Indiana *Davidson is Professor of Business Economics and Public Policy and Greblov is working towards his MBA degree at the Kelley School of Business Prepared for the Indiana Economic Development Corporation with the support of the Center for International Business Education and Research at the Indiana University Kelley School of Business. Information Services via the World Trade Atlas, U.S. State Export Edition. To receive free copies of the export report please contact the Indiana Economic Development Corporation’s Office of International Trade at 317.232.4949. Direct questions to the authors of the report to Larry Davidson at davidso@indiana.edu or 812.855.2773. Introduction This paper summarizes the results of our global pharmaceutical industry analysis and is intended to increase awareness of the general public – investors, policy makers, managers, employees of the companies – about its current developments. The paper has the following major goals: 1) To analyze the current situation, major challenges and the prospects of the pharmaceutical industry; 2) To identify major players of the global pharmaceutical industry and make a comparative analysis of their business practices and financial results; 3) To determine the relative position of the U.S. pharmaceutical...
Words: 10094 - Pages: 41